Eriksson JW - Search Results

1

Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.

Lundgren M, Svensson M, Lindmark S, Renström F, Ruge T, Eriksson JW. Lundgren M, et al. Among authors: eriksson jw. Diabetologia. 2007 Mar;50(3):625-33. doi: 10.1007/s00125-006-0572-1. Epub 2007 Jan 10. Diabetologia. 2007. PMID: 17216279

2

Vanadate increases cell surface insulin binding and improves insulin sensitivity in both normal and insulin-resistant rat adipocytes.

Eriksson JW, Lönnroth P, Smith U. Eriksson JW, et al. Diabetologia. 1992 Jun;35(6):510-6. doi: 10.1007/BF00400477. Diabetologia. 1992. PMID: 1319359

3

Cyclic AMP impairs the rapid effect of insulin to enhance cell-surface insulin-binding capacity in rat adipocytes.

Eriksson JW, Lönnroth P, Smith U. Eriksson JW, et al. Biochem J. 1992 Dec 1;288 ( Pt 2)(Pt 2):625-9. doi: 10.1042/bj2880625. Biochem J. 1992. PMID: 1334411 Free PMC article.

4

Insulin concentrations and insulin sensitivity after short-term amiloride in healthy subjects.

Eriksson JW, Fowelin J, Urbanavicius V. Eriksson JW, et al. Eur J Clin Pharmacol. 1994;46(5):469-72. doi: 10.1007/BF00191913. Eur J Clin Pharmacol. 1994. PMID: 7957545 Clinical Trial.

5

Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes.

Lönnroth P, Eriksson JW, Posner BI, Smith U. Lönnroth P, et al. Among authors: eriksson jw. Diabetologia. 1993 Feb;36(2):113-6. doi: 10.1007/BF00400690. Diabetologia. 1993. PMID: 8458524

6

A stable peroxovanadium compound with insulin-like action in human fat cells.

Eriksson JW, Lönnroth P, Posner BI, Shaver A, Wesslau C, Smith UP. Eriksson JW, et al. Diabetologia. 1996 Feb;39(2):235-42. doi: 10.1007/BF00403968. Diabetologia. 1996. PMID: 8635677

7

Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.

Yu ZW, Jansson PA, Posner BI, Smith U, Eriksson JW. Yu ZW, et al. Among authors: eriksson jw. Diabetologia. 1997 Oct;40(10):1197-203. doi: 10.1007/s001250050807. Diabetologia. 1997. PMID: 9349602

8

Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report.

Eriksson JW, Bremell T, Eliasson B, Fowelin J, Fredriksson L, Yu ZW. Eriksson JW, et al. Diabetes Care. 1998 Aug;21(8):1217-20. doi: 10.2337/diacare.21.8.1217. Diabetes Care. 1998. PMID: 9702422

9

Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes.

Axelsen M, Smith U, Eriksson JW, Taskinen MR, Jansson PA. Axelsen M, et al. Among authors: eriksson jw. Ann Intern Med. 1999 Jul 6;131(1):27-31. doi: 10.7326/0003-4819-131-1-199907060-00006. Ann Intern Med. 1999. PMID: 10391812 Clinical Trial.

10

Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?

Eriksson JW, Smith U, Waagstein F, Wysocki M, Jansson PA. Eriksson JW, et al. Diabetes. 1999 Aug;48(8):1572-8. doi: 10.2337/diabetes.48.8.1572. Diabetes. 1999. PMID: 10426375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results